|
KR20150129343A
|
|
Anti-obese composition comprising Java tumeric polysaccharides
|
|
KR20150129344A
|
|
Anti-obese and anti-diabetic composition comprising fingerroot polysaccharides
|
|
KR20100041258A
|
|
Novel use of js-1 thereof
|
|
KR20090093246A
|
|
Composition for preventing or treating a PPARα-mediated disease comprising Euchresta horsfieldii extract as a active ingredient
|
|
KR20090093302A
|
|
Pharmaceutical composition for treating or preventing an inflammatory disease comprising licarin E
|
|
KR20080035032A
|
|
Sporicidal agent against sporforming microorganism
|
|
KR20080035033A
|
|
Antibacterial agents against foodborne pathogens
|
|
KR100646574B1
|
|
Suppressant of toxicity induced by cancer chemotherapheutic agent and composition of cancer chemotherapeutic agent containing the same
|
|
KR20070014250A
|
|
Pharmaceutical composition for treating or preventing a neurological brain disease comprising xanthorrhizol
|
|
KR20070001326A
|
|
Novel ligand of nuclear receptor ppar gamma
|
|
KR100627643B1
|
|
Pharmaceutical composition for treating or preventing type ii diabetes
|
|
KR20060131012A
|
|
Pharmaceutical composition for prevention and treatment of type ii diabetes
|
|
KR100619498B1
|
|
Pharmaceutical composition for liver protection and for treating liver disease
|
|
KR20060104640A
|
|
Pharmaceutical composition for treating or preventing a neurological brain disease comprising lignan compounds
|
|
KR20060022631A
|
|
Pharmaceutical composition for treating or preventing an inflammatory disease comprising lignan compounds
|
|
KR20060075868A
|
|
New quorum sensing inhibitor
|
|
KR20060019642A
|
|
New quorum sensing inhibitor
|
|
KR20050073027A
|
|
Composition containing lignan derivatives for preventing or treating of acne
|
|
KR20050035954A
|
|
Antibacterial agent and oral composition for preventing and treating caries and periodontal disease containing lignan derivatives
|
|
KR20030089047A
|
|
Composition for enhancing oral health
|
